PLD
56
8
XYL
49
4
CTSH
56
2
CMA
61
5
MSFT
50
3
IBM
58
-2
GPC
40
3
NKE
36
6
INTU
56
-4
MAS
58
2
YUM
47
3
HAS
33
3
CF
57
-2
UPS
60
9
FE
50
-2
DRI
53
5
ZION
65
2
CHRW
56
-3
CSX
60
3
SWK
64
5
PLD
56
8
XYL
49
4
CTSH
56
2
CMA
61
5
MSFT
50
3
IBM
58
-2
GPC
40
3
NKE
36
6
INTU
56
-4
MAS
58
2
YUM
47
3
HAS
33
3
CF
57
-2
UPS
60
9
FE
50
-2
DRI
53
5
ZION
65
2
CHRW
56
-3
CSX
60
3
SWK
64
5
Financhill
Back

Neurocrine Biosciences Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57

NBIX
Neurocrine Biosciences

Last Price:
126.93
Seasonality Move:
17.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Neurocrine Biosciences Price Quote

$126.93
+1.28 (+1.02%)
(Updated: November 25, 2024 at 11:30 AM ET)

Neurocrine Biosciences Key Stats

Buy
57
Neurocrine Biosciences (NBIX) is a Buy
Day range:
$124.38 - $127.00
52-week range:
$110.52 - $157.98
Dividend yield:
0%
P/E ratio:
50.87
P/S ratio:
5.80
P/B ratio:
4.68%
Volume:
1.2M
Avg. volume:
1M
1-year change:
13.22%
Market cap:
$12.7B
Revenue:
$1.9B
EPS:
$3.73

How Much Does Neurocrine Biosciences Make?

Is Neurocrine Biosciences Growing As A Company?

Neurocrine Biosciences Stock Price Performance

What Is Neurocrine Biosciences 52-Week High & Low?

Neurocrine Biosciences Price To Free Cash Flow

Is It Risky To Buy Neurocrine Biosciences?

Is Neurocrine Biosciences Cash Flow Positive?

  • What Is NBIX Cash Flow From Operations?
    Cash flow from operations (TTM) is $476.4M
  • What Is Neurocrine Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$161.3M
  • What Is Neurocrine Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$260.3M

Neurocrine Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    NBIX return on invested capital is 15.5%
  • What Is Neurocrine Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is 11.76%
  • What Is NBIX Return On Equity?
    ROE is a measure of profitability and is 16.29%

Neurocrine Biosciences Earnings Date & Stock Price

Neurocrine Biosciences Competitors

Neurocrine Biosciences Dividend Yield

Neurocrine Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 51.22% -0.39%
Revenue: 24.72% 3.21%

Analyst Recommendations

Buy Recommendations: 15
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 163.46
Upside from Last Price: 30.09%

Major Shareholders

  • How many NBIX shares are owned by institutional investors?
    140.2M NBIX shares are owned by institutional investors
  • How many NBIX shares are owned by insiders?
    2.2M NBIX shares are owned by insiders